Institute

Back to overview
Name

Division d'Angiologie et d'Hémostase Département de Médecine Interne Hôpitaux Universitaires de Genève

Address Division d'Angiologie et d'Hémostase Département de Médecine Interne Hôpitaux Universitaires de Genève
Rue Gabrielle-Perret-Gentil 4
1211
CH-Genève
Show all

Projects

Responsible applicant Institution of higher education Start End date Funding scheme

Regulation of biosynthesis of tissue-type plasminogen activator and its inhibitor PAI-1 in human endothelial cells
Kruithof Egbert University of Geneva - GE 01.10.2010 30.09.2013 Project funding (Div. I-III)

Regulation of biosynthesis, storage and release of tissue-type plasminogen activator in endothelial cells
Kruithof Egbert University of Geneva - GE 01.10.2007 30.09.2010 Project funding (Div. I-III)

Role of microRNAs in regulating platelet reactivity in cardiovascular patients
Fontana Pierre University of Geneva - GE 01.01.2016 31.12.2018 Project funding (Div. I-III)

The regulation of plasminogen activator activity in the blood circulation. Pathophysiology of the fibrinolytic system
Kruithof Egbert University of Geneva - GE 01.10.1994 30.09.1997 Project funding (Div. I-III)

Regulation of tissue-type plasminogen activator activity in bloodcirculation. Mechanisms of release and clearance
Kruithof Egbert University of Geneva - GE 01.10.2000 30.09.2004 Project funding (Div. I-III)

Validation study of liquid crystal thermography and plasma measurement of D-dimers for screening of deep vein thrombosis following abdominal surgery
Bounameaux Henri Marie Jean Michel University of Geneva - GE 01.08.1990 31.01.1992 Project funding (Div. I-III)

Regulation of biosynthesis, storage and release of tissue-type plasminogen activator in endothelial cells
Kruithof Egbert University of Geneva - GE 01.10.2004 30.09.2007 Project funding (Div. I-III)

Genetic modification of endothelial progenitor cells to enhance their thromboresistance.
Bounameaux Henri Marie Jean Michel University of Geneva - GE 01.01.2003 30.04.2004 Project funding (Div. I-III)

Characterization of antiphospholipid antibodies and their interaction with endothelial cells
de Moerloose Philippe University of Geneva - GE 01.10.1999 30.09.2002 Project funding (Div. I-III)

Procoagulant inhibitor activity of alveolar macrophages: expression, modulation and role in ARDS
de Moerloose Philippe University of Geneva - GE 01.01.1990 31.03.1991 Project funding (Div. I-III)

Investigation of the mechanisms underlying the activation of endothelial cells by antiphospholipid antibodies
de Moerloose Philippe University of Geneva - GE 01.01.2003 31.05.2006 Project funding (Div. I-III)

Identification of epitopes recognised by antiphospholipid anti- bodies using random peptide libraries.
de Moerloose Philippe University of Geneva - GE 01.10.1997 30.09.1999 Project funding (Div. I-III)

Role of Toll-like receptors in the pathological effect of antiphospholipid antibodies: in vitro and in vivo studies
de Moerloose Philippe University of Geneva - GE 01.10.2009 30.09.2012 Project funding (Div. I-III)

A diagnostic strategy to rule out pulmonary embolism during pregnancy
Bounameaux Henri Marie Jean Michel University of Geneva - GE 01.10.2008 30.09.2012 Project funding (Div. I-III)

Evaluation of skin microcirculation in peripheral vascular diseases by means of dynamic capillaroscopy with dye ( Na- fluorescein )
Bongard Olivier University of Geneva - GE 01.04.1993 31.03.1996 Project funding (Div. I-III)

Isolation and genetic modification of endothelial progenitor cells to increase their anticoagulant potential or make them more resistant to inflammation
Bounameaux Henri Marie Jean Michel University of Geneva - GE 01.04.2004 31.03.2007 Project funding (Div. I-III)

Role of toll-like receptors and autoreactive T cells in the antiphospholipid antibody syndrome: in vitro and in vivo studies
de Moerloose Philippe University of Geneva - GE 01.10.2012 31.12.2015 Project funding (Div. I-III)

Controlled Study on the Sympathetic Function in Non-Obese, Diabetic Obese and Diabetic Non-Obese Patients.
Bongard Olivier University of Geneva - GE 01.10.1999 31.01.2001 Project funding (Div. I-III)

Utilité de l'anticoagulation en cas de TVP distale isolée symptomatique
Righini Marc University of Geneva - GE 01.10.2005 30.09.2011 Project funding (Div. I-III)
-